Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Serstech ABOSTO:SERT -0.77%36 3-Year EBITDA Growth Rate is 26.60% as of Jun. 2026, which is 17% above its 10-year median of 22.70. GuruFocus rates OSTO:SERT with a GF Score™ of 36/100 and a GF Value™ of kr0.40 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 1,409 Chemicals companies, Serstech AB ranks better than 85.95% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 26.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Serstech AB was 46.10% per year. The lowest was -79.00% per year. And the median was 22.70% per year.
Serstech AB (OSTO:SERT) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Serstech AB 3-Year EBITDA Growth Rate Related Terms
OSTO:SERT vs DOW: 3-Year EBITDA Growth Rate Comparison
For the Chemicals subindustry, Serstech AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Serstech AB 3-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Serstech AB's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Serstech AB's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 26.60% mean?
Serstech AB (OSTO:SERT) has a 3-Year EBITDA Growth Rate of 26.60% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Serstech AB and its competitors. This is 17% above median its historical median of 22.70. According to the industry distribution chart, Serstech AB ranks #198 out of 1409 companies in the Chemicals industry, placing it in the top 14.1%.
Is Serstech AB's 3-Year EBITDA Growth Rate too high?
Serstech AB's current 3-Year EBITDA Growth Rate of 26.60% is 17% above median its 10-year median of 22.70. The Chemicals industry median 3-Year EBITDA Growth Rate is 0.80. Serstech AB's value of 26.60% is 3225% above this industry median. Based on the distribution chart, Serstech AB ranks #198 out of 1409 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Serstech AB has a GF Score™ of 36/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Serstech AB's 3-Year EBITDA Growth Rate compare to DOW?
According to the Chemicals industry distribution chart, Serstech AB ranks #198 out of 1409 companies for 3-Year EBITDA Growth Rate. This places Serstech AB in the top 14% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 0.80. Serstech AB's value of 26.60% is 3225% above this benchmark. While the company's 10-year median is 22.70 vs. the industry median of 0.80, Serstech AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.80, based on 1,409 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Serstech AB's current 3-Year EBITDA Growth Rate of 26.60% is 3225% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Serstech AB and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Serstech AB's current 3-Year EBITDA Growth Rate is 26.60%, which is 17% above median its own 10-year median of 22.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Serstech AB stock overvalued right now?
Based on GuruFocus' analysis, Serstech AB (OSTO:SERT) is currently considered Modestly Overvalued. The stock's GF Value™ is kr0.40, compared to a current price of kr0.51 — trading 28.5% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 26.60%, which is 17% above median its 10-year median of 22.70 and 3225% above the Chemicals industry median of 0.80. Serstech AB's overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Serstech AB (OSTO:SERT), the current 3-Year EBITDA Growth Rate is 26.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Serstech AB (OSTO:SERT) Overvalued in 2026?
Based on GuruFocus' analysis, Serstech AB stock appears to be overvalued.
The current stock price of kr0.51 is trading 28.5% above its estimated GF Value™ of kr0.40.
GuruFocus considers Serstech AB to be Modestly Overvalued.
Key valuation signals for OSTO:SERT:
3-Year EBITDA Growth Rate: 26.60% (17% above median its 10-year median of 22.70)
GF Value™: kr0.40 vs. price of kr0.51 (28.5% above fair value)
Industry Position: 3225% above the Chemicals median (#198 of 1409)
No single metric tells the full story. See the OSTO:SERT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Serstech AB is engaged in chemical related products which help in the measurement and identification of chemicals. It offers Handheld Raman Spectrometer; Chemdash, Management and Reporting Software and Validated Data-Enriched and Complete Libraries. The company's solutions are used in the pharmaceutical production industry.
36GF Score
Get the complete analysis for OSTO:SERT
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SERT has been successfully added to your 
